TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Change from baseline in platelet aggregation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Determination of plasma peak concentration (Cmax) of ABT-199
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Determination of trough concentration (Ctrough) of ABT-199
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Determination of area under the concentration versus time curve (AUC) of ABT-199
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of Patients With Postoperative Coronal Limb Alignment More Than ±3 Deg From the Planned Coronal Limb Alignment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Diversity of nontuberculous mycobacteria species
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Changes in Visual pain scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: death at 30 days
Endpoint domain: Mortality/survival
Primary endpoint: target vessel failure
Endpoint domain: Adverse events/effects
Primary endpoint: re-acute myocardial infarction
Endpoint domain: Adverse events/effects
Primary endpoint: Perfusion of the target kidney assessed by Arterial Spin Labelling MRI
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Perfusion of the target kidney assessed by Flat-panel Detector Parenchymal Blood Volume Imaging
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Percentage of Participants with Remission
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Differentiation of radionecrosis from tumor recurrence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: BHB Concentration in blood
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Minutes at maximum exertion [Exercise Capacity]
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Left ventricular ejection fraction (%)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Post-procedure pneumoperitoneum
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Frequency of systemic involvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maternal hospital readmission
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Severe maternal morbidity (SMM) event
Endpoint domain: Adverse events/effects
Primary endpoint: 12 month morbidity and mortality
Endpoint domain: Mortality/survival
Primary endpoint: Efficacy of Autologous Melanocyte Transplantation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Evidence of definite myocardial ischemia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Time of First Post Operative Analgesic Request
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cerebral oxygen levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Treatment-emerging adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Efficacy of eplerenone
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in serum IL-6
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: serum CTX-1
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Incidence of a calcium score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Positive Percent Agreement of Blinded Visual Assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Negative Percent Agreement of Blinded Visual Assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduced recovery postoperatively according to pain measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Treadmill Walk Until Pain Initiated in Minutes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of clinically significant prostate cancer (csPCa) detection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Changes in Attention Deficit Hyperactivity Disorder (ADHD) Symptoms - Adolescent Report
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Attention Deficit Hyperactivity Disorder (ADHD) Symptom Severity - Clinician Rating
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in Attention Deficit Hyperactivity Disorder (ADHD) Symptoms - Parent Report
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Urinary excretion rate of sodium
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Plasma Tmax
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pure tone thresholds
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean Glycated Hemoglobin (A1c)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in International Knee Documentation Committee (IKDC) Subjective Knee Form Score
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Change in Tibial Articular Cartilage Volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Area under the concentration time curve (AUC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Number of Patients With Abnormal Electrochemical Skin Conductance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Minimum level of Copeptin for acute CVA diagnosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Changes from baseline BAL levels of A1AT
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Active Flexion Movement After Intervention Minus Baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Change in Active Abduction Movement After Intervention Minus Baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Change in Active extensión Movement After Intervention Minus Baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Change in Active External Rotation After Intervention Minus Baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Change in Active Internal Rotation After Intervention Minus Baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Duration of Apnea
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: D-dimers (ng/ml)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Fibrin monomers (µg/ml)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Number of cases of maternal death or severe morbidity
Endpoint domain: Mortality/survival
Primary endpoint: Number of cases of neonatal death or severe morbidity
Endpoint domain: Mortality/survival
Primary endpoint: Oral Clearance (CL/F)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patient deaths
Endpoint domain: Mortality/survival
Primary endpoint: Spinal cord neuroimage
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Adenosine Triphosphate (ATP) production
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: number of caries and white spot lesions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Medication administration error rates
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Participants With Significant Changes in Clinical Laboratory Parameters
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants With Significant Changes on the Cardiogram
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Peak load force rates for grasping
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Presence of at least one episode desaturation ≤90%
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Rate of Graded Pulmonary Exacerbations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Overall survival in LANPC
Endpoint domain: Mortality/survival
Primary endpoint: Sensory and pain depth measurements
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Dermal and thermal sensory testing evaluations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Patients Alive and Progression Free After 6 Months
Endpoint domain: Mortality/survival
Primary endpoint: Incidence of Endometriosis of the Appendix
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Incidence of valve thrombosis
Endpoint domain: Adverse events/effects
Primary endpoint: Drug safety incidents
Endpoint domain: Adverse events/effects
Primary endpoint: Postoperative blood pressure measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Antihypertensive medication use
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Number of re-hospitalization visits for VTE recurrence or bleeding
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage of remission after 14 weeks
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of remission after 26 weeks
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of remission after 38 weeks
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of remission after 50 weeks
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Duration of remission after 14 weeks
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Duration of remission after 26 weeks
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Skin numbness
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Kneeling ability
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Montreal Cognitive Assessment Score
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Arterial Pulse Waveform Contour Analysis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: changes in mental health state
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Bioavailability measured by Area Under the Curve
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cmax of paracetamol absorption
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Global rank score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: change of carotid and femoral IMT
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: occurrence of major adverse cardiovascular events (MACE)
Endpoint domain: Adverse events/effects
Primary endpoint: Proportion of Participants Experiencing an Asthma Exacerbation
Endpoint domain: Adverse events/effects
Primary endpoint: Intraoperative core-temperature decline
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Arrival temperature at post anesthesia care unit (PACU)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline in IIEF-EF domain score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline in HAM-D17 total score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Number of participants with chronic hepatitis C infection
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Persistently Elevated Serum Estradiol Level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Mean change in ocular staining (Oxford score)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CDI incidence
Endpoint domain: Adverse events/effects
Primary endpoint: Alveolar Bone quantity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction of hyper irritability
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Number of Participants Who Experience Treatment-Related Mortality (TRM) by Day 100
Endpoint domain: Mortality/survival
Primary endpoint: Time to Successful Placement of a Functioning USGIV/IO
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Number of Successful Placements
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Number of Participants With Adverse Events (AEs), Serious Adverse Events (SAEs) and Deaths
Endpoint domain: Adverse events/effects
Primary endpoint: Change From Core Study Baseline in 6 Minute Walking Distance Test (6MWD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number and rate of major bleeding events and clinically relevant bleeds
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number and rate of patients with confirmed thromboembolic and thromboembolic-related death
Endpoint domain: Mortality/survival
Primary endpoint: Number and rate of death patients (overall mortality)
Endpoint domain: Mortality/survival
Primary endpoint: Cochin Hand Function Scale (CHFS) scores
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Improvement in language abilities
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Needle tip placement accuracy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Intra-Dialytic Hypotension
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Number of Participants With No Adverse Events
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage of Patients Experiencing Pediatric Emergence Delirium
Endpoint domain: Adverse events/effects
Primary endpoint: Chronic Headache
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Chronic Backache
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Mean changes in the Hamilton Anxiety Rating Scale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Proportion of patients with hospitalization criteria
Endpoint domain: Adverse events/effects
Primary endpoint: CPFA plasmatic concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean of modified Guideline Adherence Indicator (mGAI-3)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Positive identification of language areas
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Radioactivity of 18F-DOPA following transport
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Accuracy of PET imaging compared to intraoperative pancreatic biopsy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: P-Troponin I levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Maternal complication
Endpoint domain: Adverse events/effects
Primary endpoint: Tinnitus Handicap
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Pain assessment using FLACC Behavioral Pain Scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Decrease of joint pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Outcome of mitral valve repair plus CABG vs CABG alone
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in Alzheimer's Disease Assessment Scale - Cognitive subscale (ADAS-Cog 13)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Percentage Decrease in Migraine Episodes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rescue-free Laxation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Seizure activity reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: mean of the distance of ankle movement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Number of people with a positive SARS-CoV-2 PCR
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of people with a positive SARS-CoV-2 PCR
Endpoint domain: Adverse events/effects
Primary endpoint: Number of people with a positive total immunoglobulin titer and positive IgG for SARS-CoV-2
Endpoint domain: Adverse events/effects
Primary endpoint: Prevalence of people with a positive total immunoglobulin titer and positive IgG for SARS-CoV-2
Endpoint domain: Adverse events/effects
Primary endpoint: Change in serum ALT
Endpoint domain: Physiological/clinical
Endpoint subdomain: Liver outcomes
Primary endpoint: Patient experiences following hip fracture surgery
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Carer experiences following hip fracture surgery
Endpoint domain: Life impact
Endpoint subdomain: Societal/carer burden
Primary endpoint: Change of glycemic variation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: saliva volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: quality of life related to salivation
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Difference in quality of life scores as assessed by EORTC QLQ-C30
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Difference in quality of life scores as assessed by EORTC QLQ-BR23
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Metabolic Control (HbA1c level)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Primary Outcome Description
Endpoint domain: null
Endpoint subdomain: null
Primary endpoint: Proportion of Subjects Who Achieve Platelet Control
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Proportion of Subjects Who Achieve White Blood Cell (WBC) Control
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Median Time to Neutrophil Engraftment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Mineralizing Surface/Bone Surface (MS/BS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Bone and lymphatic system outcomes
Primary endpoint: General clinical safety
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage of patients without imagiologic evidence of any stone
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: SO2 short-term variability predictive power
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Accuracy of BGMS when used by laypersons
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: modulation of the proliferation index (ki-67)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: number of end-of-life emergencies' episodes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: TUG test score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes of Childhood Autism Rating Scale-2
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes of Social Responsiveness Scale second edition
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: In-session social behavior
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Change in 18F-DTBZ Uptake
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: rate of growth of geographic atrophy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Carotenoid concentrations in plasma and in chylomicron-rich fraction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Positive serologies
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: levels of intention in prophylactic colectomy
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: frequency of mild hypoglycemia events
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Variation in Eye Pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of responders achieving > 50% seizure reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes
Primary endpoint: biodistribution of tracer
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes